However, the mechanisms through which mutations in FUS or TARDBP cause ALS and FTLD are not known, and both toxic gain-of-function and loss-of-function models have been proposed [2], [38]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.